CoChat

Prognostic Impact of Statin Use in Patients With Heart Failure and Preserved Ejection Fraction: – A Report From the CHART-2 Study –

Open access
Nochioka, Kotaro, Sakata, Yasuhiko, Miyata, Satoshi, Miura, Masanobu, Takada, Tsuyoshi, Tadaki, Soichiro, Ushigome, Ryoichi, Yamauchi, Takeshi, Takahashi, Jun, Shimokawa, Hiroaki, on behalf of the CHART-2 Investigators’ · 2015 · Circulation Journal
Cited by 65

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

BACKGROUND: The effectiveness of statins remains to be examined in patients with heart failure (HF) with preserved ejection fraction (EF). METHODS AND RESULTS: Among 4,544 consecutive HF patients registered in the Chronic Heart Failure Registry and Analysis in the Tohoku district-2 (CHART-2) between 2006 and 2010, 3,124 had EF ≥50% (HFpEF; mean age 69 years; male 65%) and 1,420 had EF <50% (HF with reduced EF (HFrEF); mean age 67 years; male 75%). The median follow-up was 3.4 years. The 3-year mortality in HFpEF patients was lower in patients receiving statins [8.7% vs. 14.5%, adjusted hazard ratio (HR) 0.74; 95% confidence interval (CI), 0.58-0.94; P<0.001], which was confirmed in the propensity score-matched cohort (HR, 0.72; 95% CI, 0.49-0.99; P=0.044). The inverse probability of treatment weighted further confirmed that statin use was associated with reduced incidence of all-cause death (HR, 0.71; 95% CI, 0.62-0.82, P<0.001) and noncardiovascular death (HR, 0.53; 95% CI, 0.43-0.66, P<0.001), specifically reduction of sudden death (HR, 0.59; 95% CI, 0.36-0.98, P=0.041) and infection death (HR, 0.53; 95% CI, 0.35-0.77, P=0.001) in HFpEF. In the HFrEF cohort, statin use was not associated with mortality (HR, 0.87; 95% CI, 0.73-1.04, P=0.12), suggesting a lack of statin benefit in HFrEF patients. CONCLUSIONS: These results suggest that statin use is associated with improved mortality rates in HFpEF patients, mainly attributable to reductions in sudden death and noncardiovascular death.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1253/circj.cj-14-0865

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 65

Metadata

Authors
Nochioka, K., Sakata, Y., Miyata, S., Miura, M., Takada, T., Tadaki, S., Ushigome, R., Yamauchi, T., Takahashi, J., Shimokawa, H., & on behalf of the CHART-2 Investigators’
Venue
Circulation Journal
Published
2015
Volume
79
Issue
3
Pages
574-582
ISSN
  • 1346-9843 (ISSN-L)
  • 1347-4820
OpenAlex
W1500521086
Cited by
65
References
8
FWCI
7.36
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Prognostic Impact of Statin Use in Patients With Heart Failure and Preserved Ejection Fraction: – A Report From the CHART-2 Study –. https://app.cochat.ai/papers/10.1253/circj.cj-14-0865
The paper
Nochioka, K., Sakata, Y., Miyata, S., Miura, M., Takada, T., Tadaki, S., Ushigome, R., Yamauchi, T., Takahashi, J., Shimokawa, H., & on behalf of the CHART-2 Investigators’. (2015). Prognostic Impact of Statin Use in Patients With Heart Failure and Preserved Ejection Fraction: – A Report From the CHART-2 Study –. Circulation Journal. https://doi.org/10.1253/circj.cj-14-0865

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.